Literature DB >> 26124383

Factors Predictive of Re-excision After Oncoplastic Breast-conserving Surgery.

Maria-Ida Amabile1, Chafika Mazouni2, Cathie Guimond1, Benjamin Sarfati1, Nicolas Leymarie1, Alexis-Simon Cloutier1, Enrica Bentivegna1, Jean-Rémi Garbay1, Frédéric Kolb1, Françoise Rimareix1.   

Abstract

BACKGROUND: Oncoplastic surgery (OPS) consists of breast-conserving surgery (BCS) that allows for oncologically safe breast conservation and breast remodeling, thus reducing postoperative deformities. The purpose of the present study was to identify factors determining the risk of re-excision and complications after OPS. PATIENTS AND METHODS: A retrospective analysis was conducted on patients who underwent OPS between 2009 and 2013, regardless of whether neoadjuvant chemotherapy was administered. Clinical and pathological factors were evaluated. Recursive partitioning analysis (RPA) was used to build regression trees for the prediction of re-excision.
RESULTS: Amongst the 129 patients treated by OPS procedures, 30.3% required re-excision. Predictive factors for re-excision were: being overweight (p=0.02), the presence of microcalcifications on mammography (p=0.003), and tumor multifocality (p=0.03). The RPA identified five terminal nodes based on microcalcifications on mammography, being overweight and the presence of ductal carcinoma in situ. Another model included minimal invasive margins (p<0.001), being overweight (p=0.02) and the presence of microcalcifications (p=0.01) on mammography yielded a model with an area under the receiver operating characteristic curve of 0.875.
CONCLUSION: Microcalcifications, tumor multifocality and being overweight were the factors identified as predictors of re-excision after OPS. These factors can serve as decisional tools before surgery. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Breast cancer; mammoplasty; mastectomy; neoadjuvant chemotherapy; oncoplastic breast-conserving surgery

Mesh:

Year:  2015        PMID: 26124383

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Magnetic Resonance Imaging after Breast Oncoplastic Surgery: An Update.

Authors:  Silvia Gigli; Maria I Amabile; Francesca Di Pastena; Lucia Manganaro; Emanuele David; Massimo Monti; Valerio DʼOrazi; Carlo Catalano; Laura Ballesio
Journal:  Breast Care (Basel)       Date:  2017-08-10       Impact factor: 2.860

2.  Fat necrosis in the Breast: A systematic review of clinical.

Authors:  Narges Vasei; Azita Shishegar; Forouzan Ghalkhani; Mohammad Darvishi
Journal:  Lipids Health Dis       Date:  2019-06-11       Impact factor: 3.876

3.  Positive or close margins: reoperation rate and second conservative resection or total mastectomy?

Authors:  Gilles Houvenaeghel; Eric Lambaudie; Marie Bannier; Sandrine Rua; Julien Barrou; Mellie Heinemann; Max Buttarelli; Jeanne Thomassin Piana; Monique Cohen
Journal:  Cancer Manag Res       Date:  2019-03-28       Impact factor: 3.989

Review 4.  Oncoplastic and Reconstructive Breast Surgery: A Comprehensive Review.

Authors:  Bulent Citgez; Banu Yigit; Soysal Bas
Journal:  Cureus       Date:  2022-01-31

5.  Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

Authors:  José H Volders; Vera L Negenborn; Pauline E Spronk; Nicole M A Krekel; Linda J Schoonmade; Sybren Meijer; Isabel T Rubio; M Petrousjka van den Tol
Journal:  Breast Cancer Res Treat       Date:  2017-12-06       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.